arrow
P

Pietro Lampertico

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico
H指数:75
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Editorial: “Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 (LGP2) Q425R Variant and Severity of Chronic Hepatitis Delta: Authors' Reply”

编者按:“宿主固有免疫进入临床——遗传与生理实验室蛋白2(LGP2)Q425R变异与慢性丁型肝炎的严重程度:作者回复”

2026-10-210
OAAI
Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab

早期肝功能失代偿与接受阿替利珠单抗联合贝伐珠单抗或度伐利尤单抗联合特瑞普利单抗治疗的HCC患者死亡率相关

2026-09-070
PRE
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy

compensated肝硬变患者中HDV RNA、HBsAg和ALT动力学的数学建模:96周bulevirtide单药治疗的启示

2026-08-010
PRE
Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity

慢性HDV感染显示出比HBV感染更高的HBsAg异构体水平,与HDV复制活性平行

Viruses
IF3.5
2026-04-300
OA
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study

基线HDV-RNA水平可在肝硬化前但不在肝硬化后分层临床风险:一项多中心欧洲研究

2026-04-200
PRE
Classification and sequencing of hepatitis D virus from a large cohort of chronically infected individuals paired with co-infecting hepatitis B virus sequencing: a genomic characterisation study

乙型肝炎D病毒分类与测序:一项基于大样本慢性感染者队列的基因组特征研究,并与共感染乙型肝炎病毒测序配对

2026-04-090
OAAI
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach

改良版Charlson合并症指数在改善肝细胞癌患者管理中的应用:迈向多参数化方法的一步

Cancers
IF4.4
2026-04-030
OAAI
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study

基于Fibrosis-4和肝脏硬度测量的护理模式对有进展性肝病风险的2型糖尿病患者的筛查有效性:来自一项意大利前瞻性多中心研究的结果

2026-02-014
PRE
TRANSCRIPTIONAL AND FUNCTIONAL HBV-SPECIFIC CD8 T CELL CHANGES FROM DISEASE TO FUNCTIONAL CURE IN HBeAg- CHRONIC HEPATITIS B

从疾病到功能性治愈过程中,HBeAg阴性慢性乙型肝炎患者转录和功能水平的HBV特异性CD8 T细胞变化

2025-12-040
OAAI
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study

HIV感染者与非感染者肝细胞癌诊断后的5年生存率比较:一项多中心研究

2025-11-181
OAAI
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT)

乙型肝炎病毒感染的管理:意大利肝病研究协会(AISF)、意大利医学肿瘤学会(AIOM)、意大利骨髓移植小组(GITMO)、意大利风湿病学会(SIR)、意大利器官移植学会(SITO)、意大利胃肠病学学会(SIGE)、意大利感染病与热带病学会(SIMIT)立场文件

2025-11-100
PRE
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Z.M.; de Avila, L.; Petta, S.; Hagström, H.; Kim, S.U.; Nakajima, A.; Crespo, J.; Castera, L.; Alkhouri, N.; Zheng, M.H.; 等. MASLD的纤维化、临床事件及死亡率的预测因素:全球MASLD研究的数据. 肝病学 2025. [Google Scholar] [CrossRef]

2025-11-013
PRE
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

非侵入性试验在MASLD中的全球表现:G-MASLD研究的见解

2025-10-010
PRE
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database

2024年意大利慢性乙型肝炎和德尔塔病毒诊断患者的估计:基于国家真实世界数据库的研究

2025-09-040
OAAI